Startseite
Märkte
Charts & Ideen
Algo
Nachrichten
Store
Broker
Herunterladen
Wirtschaftskalender
Handelssignale
WebTerminal
Geben Sie
/
ein, um zu suchen: @user, $symbol
Suche
Einloggen
Eröffnen Sie ein Konto
Deutsch
English
Русский
中文
Español
Português
日本語
한국어
Français
Italiano
Türkçe
EDAP
#3093
EDAP TMS SA
4.3
7
-1.80%
Sektor:
Basis:
Gewinnwährung:
Tagesspanne
Jahresspanne
Tagesänderung
-1.80%
Monatliche Änderung
+5.56%
6 month change
+173.12%
Jahresänderung
+65.53%
Vorheriger Schlusskurs
4.4
5
Open
4.3
7
Bid
Ask
Low
4.3
7
High
4.3
7
Volumen
2
Märkte
Aktien
Gesundheitswesen
EDAP
Open full chart
Financials
Overview
Finanzbericht
Statistics
Dividends
Quarterly
Annual
Value
Q4, 24
TTM
Key stats
Total common shares outstanding
37.39 M
144.87 M
Valuation ratios
Enterprise value
82.64 M
865.47 M
Price to earnings ratio
-4.33
169.85
Price to sales ratio
—
—
Price to cash flow ratio
—
—
Price to book ratio
—
—
Enterprise value to EBITDA ratio
—
—
Profitability ratios
Return on assets %
—
—
Return on equity %
—
—
Return on invested capital %
—
—
Gross margin %
—
—
Operating margin %
—
—
EBITDA margin %
—
—
Net margin %
—
—
Liquidity ratios
Quick ratio
—
—
Current ratio
—
—
Inventory turnover
—
—
Asset turnover
—
—
Solvency ratios
Debt to assets ratio
—
—
Debt to equity ratio
—
—
Long term debt to total assets ratio
—
—
Long term debt to total equity ratio
—
—
Per share metrics
Operating cash flow per share
—
—
EBIT per share
—
—
EBITDA per share
—
—
Total debt per share
—
—
Cash per share
—
—
Net current asset value per share
—
—
Tangible book value per share
—
—
Working capital per share
—
—
Book value per share
—
—
Nachrichten
EDAP meldet Rekordumsatz im HIFU-Segment und gibt starke Prognose für 2026 ab
EDAP reports record HIFU revenue, issues strong 2026 guidance
RBOT Enters Strategic Software Partnership to Streamline Development
AngioDynamics: Growth Remains Under The Radar (NASDAQ:ANGO)
EW Wins FDA Approval for SAPIEN M3 as First Transseptal TMVR Therapy
ISRG Gets FDA Clearance to Use da Vinci SP Robot for General Surgeries
EDAP erhält FDA-Zulassung für erweitertes robotergestütztes HIFU-System Focal One
EDAP receives FDA clearance for enhanced Focal One robotic HIFU system
Jefferies hebt Kursziel für EDAP TMS auf 2,00 US-Dollar an
EDAP TMS stock price target raised to $2.00 from $1.80 at Jefferies
EDAP: EPS übertrifft Schätzungen um 0,08 € - Umsatz besser als erwartet
EDAP earnings beat by €0.08, revenue topped estimates